Clinical Trial Update: Measure of the Long Term Influence of SPIRIVA® in Acute Respiratory Disorders [Phase 3]

View source ↗

Summary

Phase 3 trial update evaluating the long-term effects of Spiriva (tiotropium) in acute respiratory disorders; the study sponsored by Boehringer Ingelheim has co…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Obstructive Pulmonary Disease

Drugs mentioned

• Spiriva (tiotropium)

Snippet

Sponsor: Boehringer Ingelheim | Conditions: Pulmonary Disease, Chronic Obstructive | Phase 3 | Status: COMPLETED